BRTX
NASDAQ · Biotechnology
Biorestorative Therapies Inc
$0.37
+0.00 (+0.11%)
Open$0.37
Previous Close$0.37
Day High$0.39
Day Low$0.36
52W High$1.89
52W Low$0.16
Volume—
Avg Volume727.9K
Market Cap9.42M
P/E Ratio—
EPS$-1.09
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+6,973.0% upside
Current
$0.37
$0.37
Target
$26.17
$26.17
$18.72
$26.17 avg
$39.89
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.02M | 706.8K | 1.76M |
| Net Income | -40,349,779 | -25,187,127 | 288.6K |
| Profit Margin | -3,959.4% | -3,761.4% | 16.4% |
| EBITDA | -43,733,280 | -28,815,796 | 503.0K |
| Free Cash Flow | — | — | 335.8K |
| Rev Growth | +44.2% | +44.2% | +14.5% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |